Capecitabine (Cap) Combined With Bevacizumab (Bev) With or Without Vinorelbine (Vin) in First-Line Metastatic Breast Cancer (MBC): First Safety Results From the Randomized CARIN Trial.
Journal of Clinical Oncology - United States
doi 10.1200/jco.2011.29.15_suppl.1044
Full Text
Open PDFAbstract
Available in full text
Date
May 20, 2011
Authors
Publisher
American Society of Clinical Oncology (ASCO)